Objectives: To evaluate if sensory, motor, and psychological factors are different in severe lateral epicondylalgia compared with less severe cases and control.
L ateral epicondylalgia (LE) or tennis elbow affects up to 3% of the population with peak incidence occurring between 40 to 50 years of age. 1, 2 For the majority, LE is self-limiting, with an average duration of a typical episode between 6 months and 2 years. 3 However, in 2 recent randomized controlled trials, 10% and 17% of people adopting a wait-and-see policy failed to report successful outcomes after 1 year. 4, 5 Furthermore, it has been estimated that between 5% and 10% of patients develop chronic symptoms and eventually undergo surgery. 6, 7 High pain and disability at baseline is 1 of the few consistently reported indicators of poorer long-term outcome after conservative 3, 8, 9 and surgical treatment of LE. 10 For this reason, it might be valuable to identify other features that differentiate those individuals with higher pain and disability from those with lesser symptoms.
The relative simplicity of the clinical presentation of LE belies the complexity of its underlying aetiological processes. The mechanisms of pain and disability are likely multifactorial, involving an interaction of local tendon pathophysiological changes, motor impairment, nociceptive system mechanisms, 11 and possibly psychological factors. 12 Motor impairment is widespread in the affected upper limb, 13, 14 with consistent evidence of markedly reduced pain-free grip (PFG) strength being the strongest feature. 15, 16 Nociceptive system impairments in LE as measured through quantitative sensory testing have identified sensory alterations, but little is known about the distinct patterns of these changes in those who have high levels of pain and disability.
A number of studies have shown that bilateral mechanical hyperalgesia exists in LE, [17] [18] [19] whereas a nascent body of research has explored thermal hyperalgesia. [19] [20] [21] [22] Recently, Ruiz-Ruiz et al 20 reported bilateral thermal hyperalgesia in a group of 16 LE participants, whereas other investigators 23 have previously proposed that a subgroup of patients with severe LE exhibit cold hyperalgesia. Cold hyperalgesia is emerging as an important factor in other musculoskeletal disorders such as whiplashassociated disorders, with evidence that it can differentiate subgroups and help predict poor recovery over and above that of baseline pain and disability. 24, 25 In addition, Huge et al 26 identified bilateral cold and heat hyperalgesia in acute complex regional pain syndrome (CRPS), and incomplete recovery of cold pain thresholds (CPTs) in chronic CRPS in comparison to healthy controls. There is a growing interest in possible psychological factors being associated with chronic musculoskeletal conditions, for example, fear avoidance has been implicated. 27 Preliminary evidence of higher levels of depression and anxiety, which was correlated with pain and disability, has been identified in a small study of LE (n = 16), prompting a need for further evaluation of psychological factors in LE.
The aim of this cross-sectional study was to identify whether sensory, motor, and psychological factors can distinguish the subgroup of LE patients with higher pain and disability from those with lesser symptoms and a healthy control population. Comprehensive analysis might provide novel insights into the pathophysiology of the disease and mechanisms underlying delayed recovery found in patients with high baseline pain.
METHODS

Patients and Control Participants
A total of 165 participants with LE meeting the following criteria for a randomized controlled trial 28 were recruited: unilateral elbow pain over the lateral epicondyle for longer than 6 weeks and aggravated by a combination of palpation, gripping, and resisted wrist and/or finger extension. Participants were excluded if they had other upper limb conditions, such as, cervicogenic, radiohumeral or neurological, or experienced recent fractures, corticosteroid injection or physiotherapy treatment. Sixty-two healthy participants between 35 and 70 years, with no history of LE were recruited such that the control group had a similar proportion of male and female individuals to the overall LE population. Participants were excluded if they experienced concomitant neck or other arm pain that prevented participation in their usual work or recreational activities or necessitated treatment within the past 6 months. All participants were recruited from the general community through media advertisements. Ethical approval was granted by the institutional review board and informed written consent was obtained from all participants.
Measures
Pressure Pain Threshold
Pressure pain thresholds (PPTs) were measured using a digital algometer (Somedic AB, Farsta, Sweden) with probe size of 1 cm 2 , applied at a rate of 40 kPa/s until the first sensation of pain was perceived. PPTs were measured bilaterally at the lateral epicondyle and C6-C7 facet joints and over the left tibialis anterior muscle. These sites have been previously evaluated in LE, demonstrating substantial intrarater repeatability [intraclass correlation coefficient (ICC)>0.89]. 29 
Thermal Pain Thresholds
Heat pain thresholds (HPT) and CPTs were measured bilaterally over the lateral elbow using the Thermotest system (Somedic AB, Farsta, Sweden). 21 Previous studies have confirmed the reliability of these measures (ICC> 0.86). 19 From a baseline temperature of 301C, the thermode was increased or decreased at a rate of 11C/second until the first sensation of pain was perceived, or until maximum and minimum cut-out temperatures of 501C and 51C were reached.
PFG
PFG is well-established as a highly reliable (ICC> 0.97) and convenient clinical assessment tool, which correlates more strongly with disability and perceived improvement than maximal grip strength in LE populations. [30] [31] [32] It was measured using a digital grip dynamometer with variable handle position (MIE, Medical Research, UK). The participant was positioned in supine position with the tested elbow in relaxed extension and forearm in pronation, such that the palm of the hand faced down on the plinth. 28 Participants squeezed the dynamometer at a consistent rate and stopped the instant pain was experienced.
Pain, Disability, and Quality of Life
The Patient Rated Tennis Elbow Evaluation (PRTEE) was used to quantify pain and functional disability in LE. 33 The PRTEE has been validated in a magnetic resonance imaging-confirmed LE population and demonstrated good reliability and sensitivity to change. 33 Responses were scored on 11-point Likert scales with pain and disability subscales contributing equally to the total score, ranging from 0 (no pain or functional disability) to 100 (worst imaginable pain with a very significant functional disability). 33 Participants were asked to rate the level of pain currently experienced at rest and the worst level of pain experienced during the past week on 100 mm visual analog scales (VAS) with the following endpoints: no pain (0 mm) and worst imaginable pain (100 mm). Their level of function during the past week was also rated on a 100 mm VAS with endpoints: no function (0 mm) and full function (100 mm). Substantial test-retest reliability has been demonstrated for these 2 VAS measures (ICC 0.89, 0.85). 34 The EuroQol EQ-5D instrument was used to measure health-related quality of life. 35 Responses to 5 questions regarding different health dimensions were used to generate an index, ranging from 0 to 1, with 1 representing perfect health, by applying predefined scoring weights. 36 
Psychological Factors
The Hospital Anxiety and Depression Scale was measured in all participants to quantify the 2 most common forms of psychological disturbances-anxiety and depression. 37 It comprised questions rated on 4-point scales, with anxiety and depression subscales contributing equally to the total score, ranging from 0 to 42, with greater scores indicating greater anxiety and depression. The degree of kinesiophobia, also known as fear of movement or injury, 38 was assessed in the LE participants with the shortened Tampa Scale for Kinesiophobia. Each of the 11 items were scored on 4-point Likert scales giving a total score ranging from 11 to 44, with higher scores indicating greater kinesiophobia.
Procedure
After completion of relevant questionnaires, testing was performed in the following sequence: PFG, PPT, HPT, CPT. The same examiner (B.K.C.) performed all tests, without knowledge of PRTEE total scores or clustering. Tests were performed in triplicate starting on the unaffected or left side in LE or control participants respectively, with 20 seconds' intervals. Mean values were used in analyses.
To determine the reliability of quantitative sensory testing, they were measured twice in the first 46 participants with LE, separated by 1 week interval in which their condition was assumed to be stable.
Statistical Analysis
Cluster analysis (based on the K-means algorithm) of the PRTEE scores was performed using SPSS 19 (IBM, Somers, NY) to classify LE participants into 3 subgroups. This procedure, previously used in studies of other musculoskeletal conditions (eg, whiplash-associated disorders 39 ) attempts to identify homogenous groups of cases based on selected characteristics. After the formation of clusters, analysis of variance (ANOVA) was performed for each continuous outcome to compare the 3 LE groups and the control group. To account for any potential influence of hand dominance, the control group was randomly allocated a "matched affected arm" with an equivalent proportion of dominant-sided arms as that observed in the LE group. 14, 40 Sex (between-subject) and Side (within-subject) factors were included in the ANOVA model along with Group (betweensubject). Where significant side by group interactions were present, follow-up univariate ANOVA was performed separately for affected and unaffected sides. Pairwise comparisons of interest (simple effects) were followed with Bonferroni post hoc tests. Significance was nominated a priori at P<0.01. To enable comparison of effect sizes, standardized mean differences (SMDs) were calculated by dividing mean differences (MDs) relative to the control group (extracted from SPSS) by the pooled standard deviation. Absolute SMD scores >0.8 were interpreted; as a strong effect. 41 Categorical outcomes were compared between groups using w 2 analysis. ICCs and their 95% confidence intervals (CIs) were calculated using an ICC (3,1) model as a measure of test-retest reliability.
RESULTS
Analysis was performed using data from 62 healthy controls and 164 of 165 patients with LE, owing to 1 missing PRTEE questionnaire. Cluster analysis identified 3 subgroups within the LE population based on total PRTEE scores ( Fig. 1 ). The clusters, referred to herein as mild, moderate, and severe LE, showed an expected incremental increase in mean total PRTEE, supported by a similar increase in worst/resting pain and decrease in function as measured using VAS (P<0.01). Injury duration was not found to differ between LE subgroups, with the average duration being 25 weeks (range, 6 wk to 4 y). Levels of anxiety, depression, and kinesiophobia were also not significantly different between LE subgroups. No other demographic differences were found between LE and control groups, including sex, age, body mass index, manual occupation, or participation in sports involving gripping.
The severe LE cluster contained the smallest number of patients (n = 27), of which 59.3% were female. These patients were characterized by substantial worst pain levels (mean ± standard deviation 78.1 ± 16.2) and notable resting pain levels (21.8 ± 12.5 mm). Their health-related quality of life (0.59 ± 0.16) was significantly poorer, and the majority (66.7%) reported sleep disturbances due to their elbow condition. The mild LE cluster (n = 53) contained a smaller proportion (28.3%) of females and was characterized by moderate worst pain levels (50.6 ± 18.2), minimal pain at rest (6.5 ± 13.8 mm), higher quality of life (0.77 ± 0.15), and lower prevalence (32.1%) of sleep disturbance, although the latter was not statistically different to the severe group (P = 0.011). The moderate LE cluster comprised the largest number of patients (n = 84), displaying intermediary characteristics for pain, quality of life, and other clinical variables ( Table 1, 2) .
Substantial test-retest reliability (ICC>0.80) 42 was found for all quantitative sensory measures over a 1-week period (PPT elbow 0.80, PPT neck 0.84, PPT tibia 0.83, HPT 0.86, CPT 0.84). Moderate (ICC 0.79) and substantial (ICC 0.89) reliability was found for PFG testing of the affected and unaffected arms, respectively.
Thermal Pain Threshold
Analysis of pain thresholds to cold stimuli revealed significant main effects for both side (P<0.001) and group (P = 0.002) but no interaction effect (P = 0.195) (Fig. 2) . Post hoc analysis revealed only the severe LE group demonstrated significantly reduced thresholds to cold pain compared with controls, evident at both the affected (MD À6.71C, 99% CI, -11.8 to À1.61C, P<0.001, SMD À1.14) and unaffected elbow (MD À4.41C, 99% CI, À8.5 to À0.31C, P = 0.004, SMD À0.94).
Pain thresholds to heat stimuli demonstrated a significant interaction between side and group (P = 0.005). No differences were found for the unaffected elbow between controls and any of the LE groups (P = 0.172). In contrast, significant differences were found between groups for the affected elbow (P = 0.004) (Fig. 2) . Post hoc analysis revealed only the severe LE group demonstrated significantly lower HPT on the affected side in comparison with controls (MD À3.01C, 99% CI, À0.5-À 5.51C, SMD À1.06).
PPT
A significant interaction between side and group was found for PPT at the elbow (P<0.001). All 3 LE groups demonstrated significantly lower thresholds in comparison with controls (P<0.01), with differences being greater on the affected (MD À 251.5 KPa, 99% CI, À 302.1 to À 200.8, SMD À1.92, P<0.001) than unaffected elbow (MD À131.4 KPa, 99% CI, À 184.0 to À78.8, SMD À0.97, P<0.001) ( Fig. 3 ). In the affected arm, progressively lower thresholds were seen with increasing pain and disability, with the differences between the severe and mild LE subgroups being statistically significant (P = 0.005). PPT at the neck was significantly lower than controls, for all LE groups (MD À114.4 kPa, 99% CI, À163.8 to À 64.9, SMD À0.90, P<0.001). Similarly, PPT at the remote tibial site was significantly lower than controls for all LE groups (MD À102.6 kPa, 99% CI, À158.1 to À 47.1, SMD À0.84, P<0.001). There were no differences between mild, moderate, and severe LE groups for PPT at either the neck or tibia.
PFG
A significant 3-way interaction between side, group, and sex was evident for PFG (P<0.001). The affected arm of all 3 LE groups was significantly weaker than controls (P<0.001) ( Fig. 4) . Differences were significantly (P<0.001) greater in males (MD À 303 N, 99% CI, À 334.3 to À271.7, SMD À5.00) than females (MD À 177.1 N, 99% CI, À198.9 to À155.4, SMD À4.85), but proportionally (MD/control mean) they were similar (males 75.6% and females 73.4%), which is largely a function of greater normal strength in males. 43 Analysis of the unaffected arm revealed no differences between controls and any of the LE groups for either sex. 
DISCUSSION
LE patients could be clustered into subgroups according to self-rated levels of pain and disability, supported by incremental differences in corresponding pain and function VAS measures. This study is the first to show that the presence of thermal hyperalgesia in comparison with healthy controls is a distinguishing feature in LE patients with severe pain and disability. Specifically, hyperalgesia to both hot and cold were demonstrated at the affected elbow, whereas cold hyperalgesia was also evident at the un-affected elbow. Previous investigation of the thermal sensory profile of LE has revealed inconsistent findings, ranging from bilateral deficits in HPT 20 to no differences in HPT, 21, 44 or reduction of HPT in the area of pain referral. 22 Elevated CPT was found in patients with unilateral LE compared with the unaffected arm 21 and to healthy controls 19, 20 ; however, only in the most recent study by Ruiz-Ruiz et al 20 were the differences statistically significant. It is highly likely that these studies were either underpowered (the largest number of LE patients examined Results are expressed as mean and standard deviations (SD) for affected (AFF) and unaffected (UN) sides as estimated by repeated measures ANOVA adjusting for sex.
*Significantly (P<0.01) different to control group. Standardized mean differences (SMDs) were estimated by dividing mean differences from controls by the pooled SD. Positive SMD represent increased sensitivity in the LE group.
wSMD of large effect size (>0.8).
CPT indicates cold pain threshold (1C); HPT, heat pain threshold (1C); PFG, pain-free grip (N), PPT, pressure pain threshold (Kpa). was 16) or did not comprise sufficient numbers of patients with severe LE. Our findings confirm the suspicions of Smith et al 23 that cold hyperalgesia exists in a subgroup of patients with LE. The presence of thermal hyperalgesia in severe cases of LE might provide an insight into the possible underlying neurophysiological basis of a condition understood to be musculoskeletal in nature. The finding that cold hyperalgesia was bilaterally present in severe cases of unilateral LE lends support to a central mechanism being involved in these cases. [17] [18] [19] 45 Interestingly, there are similarities with CRPS 1 of the upper limb, where cold hyperalgesia has been associated with both peripheral sensitization of C-fibers and central disinhibition of nociceptive pathways secondary to A-d fiber degeneration. 26 Others 23 have proposed that cold hyperalgesia in LE may be dependent upon a sympathetic noradrenergic mechanism, based on their findings of selective improvement in CPT after guanethedine but not a control block in LE patients. They postulated that the presence of cold hyperalgesia may be a useful clinical indicator of the likely benefit of a sympathetic block; however, this requires further research. It is becoming clear that to reconcile such findings from different studies requires further research.
Apart from the likely central implications of bilateral cold hyperalgesia, the finding of heat hyperalgesia further adds to our understanding of the local neurophysiological mechanisms in LE. Heat hyperalgesia has been linked with peripheral sensitization of C-fibers. 46 Peripheral sensitization commonly occurs when nociceptors are exposed to inflammation or damaged tissue; however, other changes in the immediate tissue environment, including the concentration of neurotransmitters, growth factors, hormones, and neuropeptides, can act on the nociceptors. 47 Histologic evidence suggests LE is characterized by an absence of inflammatory mediators but high local concentrations of the excitatory neurotransmitter glutamate 48 and presence of neuropeptides, Substance P and calcitonin gene-related peptide at the origin of extensor carpi radialis brevis. 49 It is tempting to speculate that in LE where there is likely no ongoing tissue inflammation, the observed heat sensitivity might reflect centrally driven neurogenic inflammation, for which Substance P and calcitonin gene-related peptide have been implicated.
Health-related quality of life in our LE population was comparable to a previous study by Struijs et al. 50 Notably, patients with severe LE demonstrated significantly poorer quality of life than those with lower pain and disability. In addition, sleep disturbance was present in the majority (66.7%) of patients with severe LE, whereas only 32.1% of those with mild LE; however, our study may have been underpowered to detect an effect on sleep. Sleep disturbance is increasingly recognized as a common symptom in chronic pain and may be associated with a number of negative physical and psychological effects, including lowered PPT and depression. 51 In agreement with previous research, 17, 19, 52 mechanical hyperalgesia was found in the LE population at all evaluated sites and across all levels of pain and disability. A similar pattern of clinical presentation, involving spread of pain sensitivity to areas with no demonstrable pathology, is found in other musculoskeletal conditions and is thought to reflect a commonality of central sensitization to their pathophysiology. 46 In comparison to controls, large differences (Absolute SMD>0.8) were only evident at the symptomatic elbow in the mild LE group, whereas moderate and severe LE groups displayed large differences at all evaluated sites. This suggests that the transition from local to widespread hyperalgesia may be associated with increased severity (ie, greater levels of pain and disability). Investigation of the role of psychological factors in patients with LE has received limited attention. We found no difference in levels of anxiety and depression between LE groups or controls, which contrasts to the findings of Alizadehkhaiyat et al, 12 which reported significantly higher levels in 16 patients with LE compared with controls. Interestingly, our Hospital Anxiety and Depression Scale scores were much lower, even in the most severe LE group, despite displaying comparable levels of pain and disability. Varied inclusion criteria (patients with a minimum of 3 mo duration of LE were recruited from an orthopedic upper limb clinic) may potentially account for study differences. Similarly, we did not detect any difference in fear of movement between different levels of severity of LE. Our data lead us to postulate that levels of anxiety, depression, and fear of movement are relatively less important features that distinguish severe from nonsevere LE than are thermal hyperalgesia, quality of life, and sleep disturbances.
This cross-sectional study of 164 patients with LE and 62 healthy controls provides valuable groundwork toward understanding the relationships of sensory, motor, and psychological factors to an individual's pain and disability. However, there are some caveats and limitations that the reader needs to consider. First, the cross-sectional design limits any inferences regarding causal relationships between the various factors, and longitudinal studies are needed to assess their therapeutic and prognostic implications. Second, results may not be generalized to LE patients who have other concomitant musculoskeletal disorders. Third, potential bias cannot be discounted, as the examiner was not blind to the control group; however, the examiner was not aware of PRTEE clustered subgroups. Finally, multiple comparisons were conducted, a danger of which is finding statistically significant differences by chance. To reduce this possibility we set a priori P value of 0.01. Of further note, the proportion of females in the severe group was twice that of the mild LE group. Although not statistically significant, the potential influence of sex on observed findings cannot be fully ruled out.
In conclusion, this study provides evidence of thermal hyperalgesia in patients with severe LE in comparison to healthy controls. It lends support to LE representing a complex pathophysiology involving peripheral sensitization, central sensitization, and sympathetic mechanisms. Improved understanding of these physiological mechanisms may provide insight into why patients with higher initial pain demonstrate a poorer long-term outcome. Further study is needed to identify optimal treatment strategies for the subgroup of patients with severe symptoms to improve pain, disability, and quality of life outcomes.
